<DOC>
	<DOC>NCT01499602</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy of the Levonorgestrel releasing Intrauterine System (Mirena) and Norethisterone Acetate for treatment of non-atypical endometrial hyperplasia in perimenopausal women.</brief_summary>
	<brief_title>Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Endometrial Hyperplasia</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Patients with histologically confirmed simple or complex endometrial hyperplasia without atypia Endometrial hyperplasia with atypia Other pathology e.g. patients with fibroids of any size, genital infection, adnexal abnormality.</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Endometrial hyperplasia,</keyword>
	<keyword>LNG-IUS,</keyword>
	<keyword>Progestin</keyword>
</DOC>